BCG vaccine

(redirected from bacillus Calmette-Guerin)
Also found in: Dictionary, Medical.
Related to bacillus Calmette-Guerin: Bacillus Calmette-Guerin vaccine, Bacillus Calmette-Guérin

BCG vaccine

[¦bē¦sē¦jē vak′sēn]
References in periodicals archive ?
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a combined analysis of the published results of randomized clinical trials.
The Kaplan-Meier curves demonstrated the difference in tumour recurrence-free survival between patients treated with the combination therapy (immediate epirubicin and subsequent bacillus Calmette-Guerin [BCG] therapy) and BCG therapy alone.
Intravesical gemcitabine for high risk, nonmuscle invasive bladder cancer after bacillus Calmette-Guerin treatment failure.
Management of Bacillus Calmette-Guerin lymphadenitis.
Subsequently, the patient received intravesical mitomycin and bacillus Calmette-Guerin (BCG) treatment.
Delayed complications of bacillus Calmette-Guerin (BCG) vaccination in HIV-infected children.
Idiopathic disseminated bacillus Calmette-Guerin infection: a French national retrospective study.
Instillation of bacillus Calmette-Guerin (BCG) is considered more effective than chemotherapy for NMIBC, representing the first-line option in high-risk patients.
Disseminated Bacillus Calmette-Guerin infection in HIV-infected children: case report and review.
In this population, Mycobacterium bovis bacillus Calmette-Guerin (BCG) immunization (OR 53, 95% CI 13-224), a TST within 12 months (OR 24, 95% CI 1.
Reported in May 2008 interim data from the multiple dose cohort of the Phase 1, multicenter clinical trial of CG0070 in patients with recurrent superficial bladder cancer who had failed therapy with Bacillus Calmette-Guerin, or BCG, the current standard of care for this patient population.
An overview of products like I-Labelled Tositumomab (Bexxar), Y-Labelled Ibritumomab (Zevalin), Alemtuzumab (Campath), AdotrastuzumabEmtansine (Kadcyla), Bacillus Calmette-Guerin (BCG), Bevacizumab (Avastin), BrentuximabVedotin (Adcetris), Cetuximab (Erbitux), Cervarix, DenileukinDiftitox (Ontak), Gardasil, Gemtuzumab (Mylotarg), Hepatitis B Vaccine, Interferon Alfa (IFN-alfa), Interleukin-2 (IL-2), Ipilimumab (Yervoy), Ofatumumab (Arzerra), Panitumumab (Vectibix), Pembrolizumab (Keytruda), Rituximab (Mabthera), Sargramostim (Leukine), Sipuleucel-T (Provenge) and Trastuzumab (Herceptin) is provided in this research.

Full browser ?